Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Star
15386.0000 781.00 (5.35%)
NSE Oct 01, 2025 15:31 PM
Volume: 76,750
 

15386.00
5.35%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Number of FII/FPI investors increased from 250 to 259 in Jun 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended